Spain and France join the European Consortium Elixir for managing and analysing biological data Blog Post

At their meeting today in Hinxton (UK), the Board unanimously accepted Spain and France as full members of Elixir, the largest infrastructure of life science data in Europe. The National Bioinformatics Institute (INB), which acts as the Spanish scientific node, will coordinate the Spanish scientific partner institutions. These comprise top-level institutions such as CNAG-CRG and IRB Barcelona, located at PCB. The National Institute of Health Carlos III (ISCII) will coordinate the Spanish scientific partner institutions.


Artax is granted 10 million dollars to foster clinical trials with an innovative drug in patients who suffer from autoimmune disorders Blog Post

The start-up Artax Biopharma –focusing on the development of first-in-class drugs to treat autoimmune diseases- has closed a Series B series investment funding round totaling $10 Million to boost clinical trials of its most advanced compound, drug AX- 024. This biotech- based in Cambridge (Massachusetts) and founded by Damià Tormo, a scientist and entrepreneur from Valencia– leads a team in Spain that manages a large part of the project in Europe from its offices located in Valencia and at Barcelona Science Park (PCB). 


The 20 Severo Ochoa Centers of Excellence organise 100xCIENCIA Forum Blog Post

The 20 Spanish research centers accredited with the Severo Ochoa Excellence distinction– two of which are the Institute for Bioengineering of Catalonia (IBEC) and the Institute for Research in Biomedicine (IRB Barcelona), based at PCB–  met for the first time and for three days, to analyze the current situation of Spanish science and its key actors under the framework of ‘100XCIENCIA Communicating frontier science. The event, which was held from 7 to 9 October in Santa Cruz de la Palma, was closed a clear message: Science has to be conveyed to society for continued growth.


Secretary of State visits IBEC at the Barcelona Science Park Blog Post

This morning, Secretary of State for Research, Development and Innovation, Carmen Vela, visited the Institute for Bioengineering of Catalonia (IBEC) at PCB, after taking part in the opening ceremony of the conference ‘Future Tools for Biomedical Research. In Vitro, in Silico and in Vivo Disease Modeling‘, organized by B·Debate, International Center for Scientific Debate – an initiative of Biocat and “la Caixa” – jointly with IBEC. 


IBUB has participated in a international study to identify a novel gene implicated in osteoporosis Blog Post

Un uncommon variant of the gene EN1 contributes to bone mineral density and osteoporotic fractures, according to a study recently published in the journal Nature. Daniel Grinberg, expert in the Department of Genetics of the University of Barcelona (UB) and member of the Institute of Biomedicine of the UB (IBUB) at Barcelona Science Park (PCB) has participated in the study, wich is part of the international project Genetic Factors for Osteoporosis Consortium (GEFOS), funded by the European Union.  


Protein NBS1 is crucial for macrophage functional activity Blog Post

Protein NBS1, which plays a key role in DNA damage repair, is required for macrophage functional activity. This is one of the conclusions of a scientific paper published in the journal Blood—considered one of the best scientific publications in the field of haematology— and signed by a team of experts from the Faculty of Biology of the University of Barcelona (UB), Consolidated Research Group Macrophage Biology –located at the Barcelona Science Park (PCB)– and the Institute for Research in Biomedicine (IRB Barcelona). The protein also has implications for understanding the immune defects observed in patients with Nijmegen breakage syndrome and other related disorders.


Leitat leads GLAM, a European project to improve cancer diagnosis Blog Post

A European consortium led by Centre Tecnològic Leitat –through its Biomed Divisionlocated at the Barcelona Science Park (PCB)– has started the Glass-Laser Multiplexed Biosensor (GLAM) project, the aim of which is to develop a photonic-based point-of-care device for a non-invasive diagnosis of Genitourinary Cancer (GU). The GLAM project which will expand for 4 years will involve the participation of 10 European organizations with resources and capabilities from the academia and scientific and business field, among them the Institute for Bioengineering of Catalonia (IBEC), located at PCB. 


Sylvie Bove, new CEO of EIT Health Blog Post

Sylvie Bove has been appointed as new CEO of the EIT Health, the Knowledge and Innovation Community (KIC) for healthy living and active aging, promoted by the European Institute of Innovation and Technology (EIT). The Spanish node, EIT Health Spain, headed by the University of Barcelona (UB) with the support from Biocat, has its headquarters at Barcelona Science Park (PCB) and is composed of 50 core partners and 90 associate partners from the public and private sectors, leaders in their fields and committed to innovation in health. Bove took on the position on September 1


The 14th edition of the Spend the Summer at the Park! starts Blog Post

The welcome ceremony to participants of the Spend the summer at the Park! program was held today, Wednesday, July 1. The aim of this initiative –organized annually by the Barcelona Science Park (PCB)– is to bring research closer to students of any university in the world through their participation in projects currently being carried out in research groups, research centers and companies based at the PCB.